ImmunoCellular Therapeutics, Ltd. (IMUC)

USD 0.17

(0.06%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2017 2016
Revenue - - - - - -
Cost of Revenue - - - - 47.76 Thousand 75.11 Thousand
Gross Profit - - - - -47.76 Thousand -75.11 Thousand
Operating Expenses 1.81 Million 2.88 Million 2.61 Million 1.45 Million 21.15 Million 24.11 Million
Selling, General and Administrative Expenses 1.23 Million 1.65 Million 1.31 Million 756.27 Thousand 4.02 Million 5 Million
Research and Development Expenses 580.91 Thousand 1.22 Million 1.3 Million 696.71 Thousand 17.12 Million 19.1 Million
Other Expenses - - - - 7.71 Million -
Cost and Expenses 1.81 Million 2.88 Million 2.61 Million 1.45 Million 21.15 Million 24.11 Million
Operating Income -1.81 Million -2.88 Million -2.61 Million -1.45 Million -21.15 Million -24.11 Million
Interest Expense 550.72 Thousand - 8462.00 - 882.68 Thousand 1.31 Million
Income Tax Expense -167.89 Thousand -228.48 Thousand -2613.46 -1937.32 4.2 Million 1.31 Million
Earnings before Tax -1.61 Million -2.64 Million -2.67 Million -1.45 Million -14.31 Million -22.08 Million
Net Income -1.61 Million -2.64 Million -2.67 Million -1.45 Million -18.51 Million -23.39 Million
Earnings Per Share Basic -0.01 -0.02 -0.06 -0.03 -4.42 -83.60
Earnings Per Share Diluted -0.01 -0.02 -0.06 -0.03 -4.42 -83.60
Weighted Average Shares Outstanding 113.27 Million 113.27 Million 45.43 Million 45.07 Million 4.19 Million 279.88 Thousand
Weighted Average Shares Outstanding (Diluted) 113.27 Million 113.27 Million 45.43 Million 45.07 Million 4.19 Million 279.88 Thousand
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -1.06 Million -2.43 Million -1.00 - -13.38 Million -20.2 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts